RNA-based Tumor Research

A tumor refers to an abnormal lesion formed by a clonal abnormal proliferation of a certain cell in a local tissue under the action of various carcinogenic factors, which loses normal growth regulation at the gene level. In academia, tumors are generally divided into two categories: benign tumors and malignant tumors.

Oncogenes and tumor suppressor genes can cause malignant transformation of cells when they are mutated, deleted or inactivated, leading to tumorigenesis. Therefore, studying the molecular mechanism of tumorigenesis and development, and exploring oncogenes and tumor suppressor genes and their signaling pathways in different tumors and their subtypes can provide molecular markers for early diagnosis of tumors and molecular targets for drug development.It is of great theoretical and clinical significance to explore the molecular mechanism of tumor recurrence and metastasis from the gene level by using omics technology.The theory of origin of tumorig enesis mainly has some proposed theories, which can be analyzed and discussed by using big data of tumor genome. Stem cell differentiation produces some premises and mature cell populations.

We have highly qualified researchers and an experienced team to provide you with personalized experimental solutions related to RNA-based Tumor Research. With the most accurate experimental results, you can better carry out scientific research related to cancer.

RNA-based Tumor Research

Our Advantage

Mature and reliable RNA-based Tumor Research platform: rich project experience, participate in major projects, and publish high-level cooperation results.

The analysis contents and methods based on high-quality data analysis, pre-research and verification are indeed mature and feasible.

Please contact us to find out how we can help you achieve the next research breakthrough.

Learn More

* For Research Use Only. Not for use in the treatment or diagnosis of disease.

Related Services:


  • USA
  • Tel:
  • Fax:
  • Email:
  • Germany


Copyright © 2024 Creative Proteomics. All rights reserved.